Comparative inhibitory effect of a two-week short-term administration of ticlopidine and a one-month administration of cilostazol on subacute stent thrombosis

Japanese Journal of Interventional Cardiology

Volumn 19, Issue 3, 2004, Pages 250-255

  Kawata, Masahito ^a   Adachi, Kazumasa ^a   Matsuura, Akira ^a   Sakamoto, Susumu ^a  

^a AKASHI MEDICAL CENTER   (Japan)

Author keywords

Cilostazol; Subacute stent thrombosis; Ticlopidine

Indexed keywords

ACETYLSALICYLIC ACID; CILOSTAZOL; TICLOPIDINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG EFFECT; FEMALE; FOLLOW UP; HEART MUSCLE ISCHEMIA; HUMAN; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; STENT THROMBOSIS; THROMBOSIS;

EID: 3142523270     PISSN: 09148922     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Lablanche J, et al: Combined antiplatelet therapy with ticlopidine and aspirin. A simplified approach to intracoronary stent management. Eur Heart J 17: 1373-1380, 1996.
2. Moussa I, et al: Subacute stent thrombosis in the era of intravascular ultrasound-guided coronary stenting without anticoaglation: frequency, predictors and clinical outcome. J Am Coil Cardiol 29: 6-12, 1997.
3. Yosipovitch G, et al: Adverse cutaneous reactions to ticlopidine in patients with coronary stents. J Am Acad Dermatol 41: 473-476, 1999.
4. Tsui P, et al: Prolonged jaundice following percutaneous coronary intervention and ticlopidine therapy. Hong Kong Med J 8: 57-59, 2002.
5. El-Beyrouty C, et al: Cilostazol for prevention of thrombosis and restenosis after intracoronary stenting. Ann Pharmacother 35: 1108-1113, 2001.
6. Kamishirado H, et al: Randomized comparison of cilostazol versus ticlopidine hydrochloride for antiplatelet therapy after coronary stent implantation for prevention of late restenosis. Am Heart J 144: 303-308, 2002.
7. Fischman DL, et al: A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 331: 496-501, 1994.
8. Serruys PW, et al: A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 331: 489-495, 1994.
9. Leon MB, et al: A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med 339: 1665-1671, 1998.
10. Ueda Y, et al: Neointimal coverage of stents in human coronary arteries observed by angioscopy. J Am Coll Gardiol 23: 341-346, 1994.
11. Woo SK, et al: Pharmacokinetic and pharmacodynamic modeling of the antiplatelet and cardiovascular effects of cilostazol in healthy humans. Clin Pharmacol Ther 71: 246-252, 2002.
12. DiPerri T, et al: Pharmacodynamics of ticlopidine in man in relation to plasma and blood cell concentration. Eur J Clin Pharmacol 41: 429-434, 1991.
13. Colombo A, et al: Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 91: 1676-1688, 1995.
14. Marzocchi A, et al: Antithrombotic therapy after coronary stent placement. Cardiologia 43: 717-723, 1998.
15. Sayin T, et al: Angiographic and clinical follow-up after coronary implantation of the ACS Multilink Duet stent: a single center experience. Jpn Heart J 42: 409-416, 2001.
16. Moses JW, et al: Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349: 1315-1323, 2003.
17. Moussa I, et al: Subacute stent thrombosis and the anticoagulation controversy: changes in drug therapy, operator technique, and the impact of intravascular ultrasound. Am J Cardiol 78: 13-17, 1996.
18. Bhatt DL, et al: Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting. J Am Coil Cardiol 39: 9-14, 2002.